Objectives: Coronary artery bypass surgery (CABG) using conventionally harvested saphenous vein (SV) as a graft is characterised by a high graft failure rate. It is believed that vein handling during harvesting is responsible for this, as damage to the vein's structure including its sources of endothelial nitric oxide synthase (eNOS) is apparent. Here we investigated the distribution of inducible nitric oxide synthase (iNOS) in conventionally harvested SV grafts and grafts prepared by a less-invasive 'no-touch' technique for CABG. Focus was on vascular smooth muscle cells (VSMCs). Patients and methods: Six patients undergoing CABG were selected for the study; their SVs were harvested as grafts by conventional and 'no-touch' techniques and subsequently examined using fluorescent and transmission electron microscopy combined with immunolabelling to detect iNOS and structural changes in the grafts at the time of implantation. Results: The following were observed in conventionally harvested grafts: (i) damage to the VSMCs and (ii) induction of iNOS in these cells, (iii) heterogeneity of VSMCsdthe presence of iNOS-positive and iNOS-negative VSMCs which were also (iv) in close contact with each other. In contrast, no damage to VSMCs and no expression of iNOS in these cells were observed in the 'no-touch' SV preparations.
Introduction
The human saphenous vein (SV), when harvested conventionally for coronary artery bypass grafting (CABG), is stripped of surrounding connective tissue including the adventitia; this provokes the vein to go into spasm, and to overcome this the SV is distended prior to grafting. 1e3 Failure of grafts harvested this way is relatively high, with 10e20% of grafts occluding within the first year and over 50% within 10 years. 4, 5 These conventional harvesting procedures induce ultrastructural changes in SV grafts 3, 6, 7 including alterations in vascular smooth muscle cells (VSMCs). 8 Conventional harvesting also removes substantial sources of endothelial nitric oxide synthase (eNOS) and hence nitric oxide (NO) due to damage and loss of the endothelium and the vasa vasorum. 9e12 It has been observed that reduced manual manipulation of grafts during venous or arterial surgery ('dissection without touching') results in better preservation of the endothelium. 2 One further improvement in harvesting has been described, a 'no-touch' technique, which minimises mechanical trauma to SVs used for CABG, by conserving the surrounding connective tissue and not distending the vein. 3 This less invasive harvesting technique improves the outcome of CABG and increases both early and long term patency rates of SV grafts. 13, 14 Recent results of 8.5 years follow-up angiographic and intravascular ultrasound (IVUS) studies have shown higher patency rates of 'no-touch' SV grafts, 92%, versus 78% for conventionally harvested grafts. 14 To minimise venous graft failure, a broader acceptance of the 'no-touch' technique for CABG surgery has now been recommended. 15 Using fluorescence and transmission electron microscopy combined with immunolabelling we have focused on the distribution of inducible nitric oxide synthase (iNOS) and the structure of VSMCs in 'no-touch' (normal) and conventionally harvested SV used in patients undergoing CABG.
Patients and methods

Patients: clinical data
Samples of SV were obtained from six patients, two women and four men, 54e70 years of age, undergoing CABG surgery at the Department of Cardiothoracic Surgery, Örebro University Hospital, Örebro, Sweden. Ethical approval and patients' informed consent were obtained for the study. The patients were selected to represent as closely as possible the same medical history and conditions. The patients were free of diabetes, suffered from angina and heart failure NYHA class III; they were smokers and were receiving aspirin and beta-blockers before surgery.
SV samples
During CABG surgery a proximal segment of the SV was harvested (within 1 h) with its surrounding adventitia and peri/paravascular connective tissue using the 'no-touch' technique. 3 Adjacent segments were stripped of surrounding tissue and adventitia, and distended with saline at a pressure of 300 mmHg for 1 min using a syringe connected to a manometerdthe conventional technique. Both SV segments were stored for about 30 min at room temperature in heparinised patient's blood (obtained from the aortic cannula) before implantation. 16 Samples of excess SV grafts were taken from the two (conventional and 'no-touch') segments on completion of the proximal anastamosis and processed for fluorescence-immunohistochemistry and electron-immunocytochemistry.
Fluorescence-immunohistochemistry
To examine the general aspects of iNOS distribution, samples from excess SV segments were fast frozen and stored at ÿ70 C. Using a Reichert-Jung CM1800 cryostat, specimens were then cross-sectioned at 15 mm and collected onto polylysine-coated microscope slides for the immunoprocedure. In brief, sections were (i) washed in 0.1 M phosphate-buffered saline (PBS), (ii) placed for 1 h in 10% non-immune normal horse serum (Jackson ImmunoResearch Laboratories West-Grave, PA, USA) in PBS containing 0.1% sodium azide, (iii) incubated for 24 h at 8 C with a polyclonal antibody to iNOS at a dilution of 1:200 in PBS (containing 10% non-immune normal horse serum and 0.1% sodium azide), (iv) washed in PBS, (v) incubated for 1 h with biotin-conjugated donkey anti-rabbit IgG serum (Jackson) diluted 1:500 in PBS, (vi) washed in PBS, (vii) exposed for 1 h to Streptavidin-Texas red (Amersham, Biosciences, Little Chalfont, UK) diluted 1:200 in PBS. Sections were then washed in PBS and mounted in Citifluor (Citifluor Ltd., London, UK) for examination with a Zeiss Axioplan fluorescence microscope (Zeiss, Germany) with a Leica DC200 digital camera. Fluorescence filters (568 excitation line) allowed observation of labelling with Texas red; objective lenses with 10Â and 20Â (dry aperture) and 40Â and 63Â (oil immersion) were used for examination of the specimens. Images were stored digitally.
Electron-immunocytochemistry
For ultrastructural purposes, samples of SV were fixed overnight at 4 C by immersion in fixative consisting of 4% paraformaldehyde and 0.2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). After fixation, SV were transferred to 0.1 M phosphate buffer containing 0.1% sodium azide, cross-sectioned at~100 mm using a vibratome, collected in 0.1 M Tris buffered-saline (TBS), at pH 7.6, and processed for the pre-embedding ExtrAvidin immunocytochemical method. In brief, sections were (a) exposed to 0.3% hydrogen peroxide in 33% ethanol for 45 min (in order to block endogenous peroxidases), (b) washed in TBS, (c) placed for 1 h in 10% non-immune normal horse serum, (d) washed in TBS, (e) incubated for 24 h at 8 C with a polyclonal antibody to iNOS (as above) at a dilution of 1:400 in TBS containing 10% nonimmune normal horse serum and 0.1% sodium azide, (f) washed in TBS, (g) incubated for 16 h at 8 C with biotin-conjugated donkey anti-rabbit IgG serum (Jackson) diluted 1:500 in TBS containing 1% nonimmune normal horse serum and 0.1% sodium azide, (g) washed in TBS, (h) exposed for 5 h at 8 C to ExtrAvidin-horseradish peroxidase conjugate (Sigma, Poole, UK) diluted 1:1500 in TBS, and then (i) washed in TBS. Immunoreactivity was visualised with diaminobenzidine (Sigma). After extensive rinsing in TBS and distilled water, sections were placed in 1% osmium tetroxide in 0.1 M sodium cacodylate buffer for 1 h (at 4 C), and then washed in sodium cacodylate buffer, dehydrated in a graded series of ethanol and propylene oxide, flat embedded in Araldite and polymerised. Ultrathin sections were stained with uranyl acetate and lead citrate, and subsequently examined and photographed using either a JEOL-1010 or Philips CM-120 transmission electron microscope.
Immunocytochemical controls
Rabbit polyclonal anti-human iNOS antibody (SC-651) (directed against an N-terminal peptide (amino acids 3e22) of human iNOS) was manufactured and characterised by Santa Cruz Biotechnology (Santa Cruz, CA). The antibody specifically detects iNOS and does not cross-react with human eNOS or nNOS. In the present study, the routine omission of the iNOS antibody and IgG steps, independently, resulted in a lack of immunolabelling; these controls were performed both at the light (fluorescence) and electron microscopic levels.
Results
General features of SV segments harvested by the 'no-touch' and conventional techniques are diagrammatically summarised in Fig. 1 ; these features apply to all the 'no-touch' and conventional preparations, respectively, examined in this study. 'No-touch' SV retained a normal architecture; a cushion of surrounding connective tissue was preserved, and the luminal folds were present ( Fig. 1a ). In contrast, in SV harvested conventionally, the cushion of connective tissue was removed and the vein was distended. There was thinning of the media and dilation of the lumen caused by distension ( Fig. 1b ).
Fluorescence-immunohistochemistry
Immunoreactivity for iNOS was seen in the tunica media of all segments of conventionally harvested SV examined ( Fig. 2aec ), whilst the media of both 'no-touch' and the immunocytochemical control SV specimens were essentially free of iNOS immunoreactivity ( Fig. 2d,e ). Immunoreactivity for iNOS was mostly located in the cells of the media (Fig. 2b ). Also cells located at the edges of the SV wall, where the adventitia had been removed, displayed strong labelling for iNOS ( Fig. 2c ). Variations in shape and size of the labelled cells were noticeable.
Electron-immunocytochemistry
Electron microscopic examination revealed changes throughout the tunica media of all segments of conventionally harvested SV as compared with those harvested using the 'no-touch' technique. The VSMCs displayed polymorphism where a number of cells contained vacuoles of various sizes, some of which occupied a substantial part of the cell cytoplasm. Under immunocytochemical investigation these vacuolated VSMCs showed immunoreactivity for iNOS ( Fig. 3a) . The immunoreactivity was associated with the cytoplasm, whilst no immunolabelling was observed within intracellular vacuoles, which were electrontransparent. Vacuolated and non-vacuolated medial VSMCs were also present close to the edge of the SV wall, where the adventitia had been removed during harvesting. These cells were either positive or negative for iNOS ( Fig. 3b ). Regardless of the region of the tunica media in which iNOSpositive VSMCs were present, these cells showed cytoplasmic disorders. It was not uncommon in the tunica media to observe neighbouring undamaged iNOS-negative VSMCs and damaged iNOS-positive cells. Features common to conventionally harvested grafts were contacts established between iNOS-positive and iNOS-negative VSMCs (Fig. 3a, inset) . Some of the iNOS-negative VSMCs engaged in cell-to-cell contacts displayed vacuolated cytoplasm at the cell's perinuclear regions. The nuclei of the cells displayed features of mitotic activity (Fig. 4) .
Under higher electron microscopic magnification, more precise locations of immunoprecipitate were detected in iNOS-positive VSMCs. In particular, the location of iNOS immunoreactivity on/in endoplasmic reticulum and strands of cytoplasm was apparent (Fig. 5a,b) . Furthermore, the caveolae of the VSMC plasmalemma were immunolabelled ( Fig. 6a,b) . The labelled caveolae were also identified at the cell-to-cell contacts (Fig. 6c ).
There was no evidence of iNOS immunoreactivity in VSMCs of 'no-touch' preparations of SV (Fig. 7 , also see Fig. 2d ); these appeared similar to negative immunocytochemical control preparations (not shown). Also VSMCs of 'no-touch' preparations displayed 'normal' structure.
Discussion
The present study showed that segments of SV conventionally harvested for CABG expressed immunoreactive iNOS in VSMCs which were structurally altered (damaged) and those segments harvested with the 'no-touch' method, were free of immunoreactivity and the structure of cells was well preserved.
Previous studies of SV used for CABG showed that conventional harvesting significantly impairs NO activity making the graft prone to pathological changes including stenosis after implantation. 17 In fact, conventional harvesting may lead to an almost complete abolition of NO release from the SV graft. 18 The general presence of NOS in human SV used for CABG has been demonstrated using NADPH-diaphorase histochemistry 19 and reduced levels of eNOS in conventional compared to 'notouch' SV has been reported using Western blot analysis and light microscopic immunohistochemistry. 10 The reduction in eNOS content of conventionally harvested SV is not surprising as the structural damage to the vein, including its sources of NOdthe endothelium and the vasa vasorumdis severe at the time of implantation. 7, 8, 11 Furthermore, progressive vascular changes, including a differential Figure 1 General diagram of the structure of 'no-touch' (a) and conventional (b) SV grafts for CABG examined in this study. In (a) note the presence of a pronounced pedicle of peri/paravascular connective tissue including adventitia and the existence of intimal folds projecting from the lumen into tunica media. In (b) note a drastic change in the vein's appearance. The wall is thin; the pedicle of connective tissue is absent due to its removal during harvesting; also absent are the intimal folds due to the vein distension (with saline at a pressure of 300 mmHg for 1 min). Bar: 1 mm. reduction in eNOS, have been observed in explanted aorto-coronary SV grafts coinciding with regions of intimal hyperplasia and focal sites of atherosclerosis. 20 
Role of iNOS in VSMCs
Our study showed iNOS expression in damaged VSMCs of conventionally harvested SV at the time of implantation. The role of iNOS from VSMCs of SV used for CABG is not clear. Both protective and harmful effects of iNOS/NO may be considered. One of the first studies that showed a significant increase of iNOS gene expression in human SV used as aorto-coronary grafts suggested that this phenomenon could be linked with iNOS involvement in graft patency. 21 This study was based on failed SV grafts available at the time of redo CABG operations performed several years after implantation to the coronary vascular bed. Taken together our data and that of Dattilo et al. 21 suggests that iNOS is rapidly induced (by mechanical trauma) in conventionally handled SV for coronary grafts, and that iNOS expression in such grafts may be sustained for months or even years. Furthermore, NO generated by iNOS in VSMCs may compensate for the intimal damage that occurs during harvesting, and the loss of eNOS-derived NO from disrupted endothelial cells. The NO generated from VSMCs by iNOS would therefore be expected to restore vascular homeostasis after injury, 22, 23 such as that inflicted to the SV during conventional harvesting for CABG. Studies of rat aortic allografts showed that iNOS protects the grafts against the development of arteriosclerosis. 24 Increased iNOS expression and hence NO production may restrict both thrombotic and proliferative responses in injured vessels, 25 yet the longterm elaboration of iNOS in SV grafts seems unable to prevent graft failure 21 despite NO being produced by VSMCs after injury and responses to cytokine stimulation. 22, 23 There is evidence that expression of iNOS in VSMCs (and also macrophages and foam cells) is associated with atherosclerosis and that the activity of iNOS, stimulated by atherosclerosis-associated inflammatory cytokines, promotes the formation of harmful (cytotoxic) peroxynitrite. 26 A continuously high activity of iNOS leading to increased superoxide production and peroxynitrite formation 27,28 might thus have further 'negative' effects on graft patency.
Heterogeneity of VSMCs and iNOS expression
Our study showed that iNOS was rapidly induced in the subpopulation of VSMCs structurally altered by conventional handling of the SV for CABG. Thus, both structural and immunohistochemical heterogeneity of VSMCs in conventionally harvested SV was apparent; many structurally damaged VSMCs were iNOS-positive, whilst those well preserved were iNOS-negative. The subcellular mechanisms of this selective induction of iNOS in VSMCs of SV are unknown at this stage. The possibility that distension (stretch) of the vein media (wall) stimulates NO release from iNOS-positive VSMCs needs to be examined in detail since it is known that stretch stimulates eNOS and subsequent NO release from the endothelium. 29 Studies of balloon-injured (distended) rat arteries, have shown increased iNOS expression in VSMCs, and raised NO output from intimal/neointimal compared with medial VSMCs. Furthermore, these elevated levels of NO reduced VSMC proliferation, although the intimal appeared less sensitive to NO than the medial cells. 23 Our studies showed the heterogeneous capability of VSMCs to express iNOS in the early response of the vein to surgical mechanical stress, including distension. 
Subcellular iNOS localisation in VSMCs
High magnification electron microscopic images of immunolabelled VSMCs showed iNOS-immunoreactivity associated with the plasmalemmal caveolae system, the compartment of the cells that is implicated in NOS activity and NO biosynthesis. 30e35 In endothelial cells, transient increases of intracellular Ca 2þ promotes translocation of eNOS from caveolae to the cytosol, and subsequent NO release. 31e33 Whether iNOS detected in VSMCs undergoes a similar translocation at the caveolae is unknown. It is possible that clustered and diffuse immunoprecipitate observed at caveolae reflects translocation of iNOS and different states of iNOS activity.
Contacts between iNOS-positive and iNOS-negative VSMCs
Another striking finding, that may be relevant to the expression of iNOS and the protective function of NO, is the existence of contacts between iNOSpositive and iNOS-negative VSMCs. As a protective feature, such contacts would be expected to facilitate the inhibitory property of NO on neighbouring VSMC mitogenesis, proliferation and migration and thus on NO-inhibition of intimal hyperplasia and atherosclerosis. 36e38 However, raised NO availability may also promote superoxide generation and VSMC growth. 39 We have recently shown proliferation of intimal VSMCs in conventionally harvested SV 40 in agreement with ultrastructural findings. 8 A study of the dog SV graft to femoral artery revealed early remodelling of the vein graft in which, alongside mitogenesis and proliferation, cell apoptosis in the media and adventitia were reported. 41 Features of apoptosis of VSMCs in conventionally harvested SV are supported by ultrastructural observations. 8 Whether contacts between iNOS-positive and iNOS-negative VSMCs observed in this study have any role in up-regulation of iNOS/NO to influence, e.g. tissue repair 42 or suppress iNOS, 43 is unknown at this stage. There is considerable complexity of the regulation of iNOS in human VSMCs. 44 NO involvement in venous reactivity may have particular significance during pathophysiological circumstances or mechanical damage such as inflicted during CABG.
Conclusions
The conventional harvesting of SV for CABG rapidly stimulates the expression of iNOS in VSMCs, which are structurally altered by harvesting. It is therefore concluded that harvesting techniques influence the structure of VSMCs and the expression of iNOS in the SV graft at the time of implantation. Whether this has beneficial or harmful effects in conventional SV as coronary graft remains open for discussion.
